Torrey Pines Therapeutics Sells Alzheimer’s Program to Partner
Bruce V. Bigelow11/10/08
TorreyPines Therapeutics (NASDAQ:TPTX) says it has agreed to sell its Alzheimer’s disease genetics research program for $1.5 million to partner Eisai Co. TorreyPines will record the payment from the Nov. 6 deal in its fourth quarter financial results, the company said today in a filng with government regulators.
Bruce V. Bigelow is the editor of Xconomy San Diego. You can e-mail him at bbigelow@xconomy.com or call (619) 669-8788
Minding Your Business » Blog Archive » Tuesday Morning Business Briefing
11/11/08 8:53 am
[...] Local/state business news: * Goldman Sachs urged bets against California bonds it helped sell, report says * Tri-City Hospital nixes expensive earthquake safety extension proposal * Torrey Pines Therapeutics sells Alzheimer’s program for $1.5M [...]